Dennis L Johnson, MD | |
300 Portland St Ste 110, Columbia, MO 65201-7390 | |
(573) 886-4600 | |
(573) 886-4695 |
Full Name | Dennis L Johnson |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 300 Portland St Ste 110, Columbia, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760430052 | NPI | - | NPPES |
202656914 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | R4J21 (Missouri) | Primary |
Entity Name | Boyce & Bynum Pathology Professional Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1689634818 PECOS PAC ID: 0042384976 Enrollment ID: O20080811000335 |
News Archive
Exposure in the womb to bisphenol A (BPA) - a chemical used to make plastic containers and other consumer goods - is associated with behavior and emotional problems in young girls, according to a study led by researchers at Harvard School of Public Health (HSPH), Cincinnati Children's Hospital and Medical Center, and Simon Fraser University in Vancouver, British Columbia.
Anxiety, the most common family of mental illnesses in the U.S., has been pushed to epic new heights by the COVID-19 pandemic, with the Centers for Disease Control and Prevention estimating that nearly 1 in 3 U.S. adults and a staggering 41% of people ages 18-29 experienced clinically significant anxiety symptoms in late August.
The recently published National Immunization Survey (NIS) conducted by the CDC, shows that the majority of infants in the US were vaccinated against potentially serious diseases in 2013. Fewer than 1% of children were unvaccinated in 2013.
NexBio, Inc. announced today the initiation of a trial of DAS181 (Fludase®) in patients with the respiratory conditions asthma and bronchiectasis, being conducted by researchers with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). This trial will examine the effects of DAS181 in subjects with well-controlled or stable pulmonary disease.
A new area of ground-breaking research to provide a better understanding of the cause, treatment and prevention of Chronic Fatigue Syndrome/ME in children has secured a prestigious fellowship and funding of £730,000.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dennis L Johnson, MD 300 Portland St Ste 110, Columbia, MO 65201-7390 Ph: (573) 886-4600 | Dennis L Johnson, MD 300 Portland St Ste 110, Columbia, MO 65201-7390 Ph: (573) 886-4600 |
News Archive
Exposure in the womb to bisphenol A (BPA) - a chemical used to make plastic containers and other consumer goods - is associated with behavior and emotional problems in young girls, according to a study led by researchers at Harvard School of Public Health (HSPH), Cincinnati Children's Hospital and Medical Center, and Simon Fraser University in Vancouver, British Columbia.
Anxiety, the most common family of mental illnesses in the U.S., has been pushed to epic new heights by the COVID-19 pandemic, with the Centers for Disease Control and Prevention estimating that nearly 1 in 3 U.S. adults and a staggering 41% of people ages 18-29 experienced clinically significant anxiety symptoms in late August.
The recently published National Immunization Survey (NIS) conducted by the CDC, shows that the majority of infants in the US were vaccinated against potentially serious diseases in 2013. Fewer than 1% of children were unvaccinated in 2013.
NexBio, Inc. announced today the initiation of a trial of DAS181 (Fludase®) in patients with the respiratory conditions asthma and bronchiectasis, being conducted by researchers with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). This trial will examine the effects of DAS181 in subjects with well-controlled or stable pulmonary disease.
A new area of ground-breaking research to provide a better understanding of the cause, treatment and prevention of Chronic Fatigue Syndrome/ME in children has secured a prestigious fellowship and funding of £730,000.
› Verified 8 days ago
Thomas Bart Shaw, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 300 Portland St Ste 110, Columbia, MO 65201 Phone: 573-886-4600 Fax: 573-886-4695 | |
Charles W Caldwell, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1013 Marcassin Dr, Columbia, MO 65201 Phone: 573-442-8442 | |
Paul J Mcgowan, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 300 Portland St Ste 110, Columbia, MO 65201 Phone: 573-886-4600 Fax: 573-886-4695 | |
Lester J. Layfield, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-1201 Fax: 573-884-4612 | |
Grant Van Dyke Darkow, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 300 Portland St Ste 110, Columbia, MO 65201 Phone: 573-886-4600 Fax: 573-886-4695 | |
Anna Venneman, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 300 Portland St Ste 110, Columbia, MO 65201 Phone: 573-886-4600 Fax: 573-886-4695 | |
Dr. Douglas Roy Mitchell, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 200 Portland St, Columbia, MO 65201 Phone: 573-886-4600 |